Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women with polycyctic ovary syndrom who tend to participate in research Age range of 20-40 years old
Exclusion criteria
Exclusion criteria: Pregnancy decision during the study period Having a allergy and intolerance to Green Coffee supplement Taking steroidal and non-steroidal anti-inflammatory drugs The precence of thyroid and kidney disorders Consumption of nutritional supplement other than calcium, iron and folic acid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Paraoxonase-1 level. Timepoint: At the begining and at the end of the study (after 40 days). Method of measurement: ELISA.;Malondialdehyde level. Timepoint: At the begining and at the end of the study (after 40 days). Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cholestrol. Timepoint: At the beginning of and at the end of study (after 40 days). Method of measurement: Auto Anelyzer.;Triglycerid. Timepoint: At the begining and at the end of study (after 40 days). Method of measurement: Auto anelyzer.;LDL. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Auto anelyzer.;HDL. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Auto anelyzer.;Fasting blood glucose. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Auto anelyzer.;Insulin. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Elisa. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University